{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:46:50Z","timestamp":1793371610654,"version":"4.5.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00105-025-05476-2","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:46:05Z","timestamp":1738611965000},"page":"220-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intral\u00e4sionales Rituximab bei refrakt\u00e4rem Granuloma faciale","Intralesional rituximab for refractory granuloma faciale"],"prefix":"10.1007","volume":"76","author":[{"given":"Lea","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"L\u00f6ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindaugas","family":"Andrulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Dippel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"issue":"1","key":"5476_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/PAS.0b013e318271efd0","volume":"37","author":"AM Cesinaro","year":"2013","unstructured":"Cesinaro\u00a0AM, Lonardi\u00a0S, Facchetti\u00a0F (2013) Granuloma faciale: a\u00a0cutaneous lesion sharing features with IgG\u00a04-associated sclerosing diseases. Am J Surg Pathol 37(1):66\u201373","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"5476_CR2","first-page":"319","volume":"15","author":"FC Eberle","year":"2017","unstructured":"Eberle\u00a0FC, Holstein\u00a0J, Scheu\u00a0A, Fend\u00a0F, Yazdi\u00a0AS (2017) Intral\u00e4sionale Therapie niedrig maligner prim\u00e4r kutaner B\u2011Zell-Lymphome mit anti-CD20-Antik\u00f6rper: Nebenwirkungen korrelieren mit gutem klinischen Ansprechen. J\u00a0Dtsch Dermatol Ges 15(3):319\u2013324","journal-title":"J Dtsch Dermatol Ges"},{"key":"5476_CR3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/978-3-662-53647-6","volume-title":"Dermatologie Venerologie: Grundlagen. Klinik. Atlas","author":"P Fritsch","year":"2018","unstructured":"Fritsch\u00a0P, Schwarz\u00a0T (2018) Eosinophile Dermatosen. In: Dermatologie Venerologie: Grundlagen. Klinik. Atlas. Springer, Berlin, S\u00a0424"},{"issue":"4","key":"5476_CR4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.annder.2021.06.001","volume":"148","author":"E Joly","year":"2021","unstructured":"Joly\u00a0E, Duval-Modeste\u00a0A, Sabatier\u00a0R, Arhant\u00a0G, Cellier\u00a0L, Mouthon\u00a0M, Comoz\u00a0F, Joly\u00a0P, Dompmartin\u00a0A (2021) Intralesional rituximab treatment for atypical refractory granuloma faciale. Ann Dermatol Venereol 148(4):272\u2013274","journal-title":"Ann Dermatol Venereol"},{"issue":"11","key":"5476_CR5","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jamadermatol.2018.2681","volume":"154","author":"D Morgado-Carrasco","year":"2018","unstructured":"Morgado-Carrasco\u00a0D, Giavedoni\u00a0P, Mascar\u00f3\u00a0JM Jr, Iranzo\u00a0P (2018) Assessment of treatment of refractory granuloma faciale with Intralesional rituximab. JAMA Dermatol 154(11):1312\u20131315","journal-title":"JAMA Dermatol"},{"key":"5476_CR6","first-page":"659","volume-title":"Braun-Falco\u2019s dermatologie, venerologie und allergologie","author":"K Reich","year":"2018","unstructured":"Reich\u00a0K, Mrowietz\u00a0U (2018) Granuloma faciale. In: Braun-Falco\u2019s dermatologie, venerologie und allergologie. Springer, Berlin, S\u00a0659\u2013660"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05476-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-025-05476-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05476-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T13:04:19Z","timestamp":1742994259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-025-05476-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5476"],"URL":"https:\/\/doi.org\/10.1007\/s00105-025-05476-2","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"19 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Braun, C.\u00a0L\u00f6ser, M.\u00a0Andrulis, M.\u00a0Uhl, M.\u00a0Wolter und E.\u00a0Dippel geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}